Păunescu V, Simici P
Med Interne. 1986 Jul-Sep;24(3):191-6.
For the prevention of postoperative thromboembolic complications (TEC) in patients with thromboembolic risk, heparin was administered subcutaneously in small doses, adapted to each patient. The efficiency of each method was confirmed clinically by the absence of TEC, verified by the administration of labelled fibrinogen and by the anatomopathologic examination. In contrast, in the control group there were 3.93% cases of TEC with 0.97% fatal pulmonary embolism. The local complications of heparin treatment depend upon the type of product administered. The method has advantages but also certain drawbacks that require the taking of all pre-, intra- and postoperative measures for prevention of TEC.
为预防有血栓栓塞风险患者的术后血栓栓塞并发症（TEC），对每位患者皮下注射小剂量肝素。每种方法的有效性通过无TEC在临床上得到证实，这通过注射标记纤维蛋白原及解剖病理学检查来验证。相比之下，在对照组中，TEC发生率为3.93%，致命性肺栓塞发生率为0.97%。肝素治疗的局部并发症取决于所使用产品的类型。该方法有优点，但也有某些缺点，这就需要采取所有术前、术中和术后措施来预防TEC。
